Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Gains from Investment Securities: 2017-2021

Historic Gains from Investment Securities for Cogent Biosciences (COGT) over the last 4 years, with Sep 2021 value amounting to $3.7 million.

  • Cogent Biosciences' Gains from Investment Securities fell 50.20% to $3.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $3.7 million, marking a year-over-year decrease of 61.54%. This contributed to the annual value of $100,000 for FY2024, which is 83.33% down from last year.
  • Latest data reveals that Cogent Biosciences reported Gains from Investment Securities of $3.7 million as of Q3 2021, which was down 10.17% from $4.1 million recorded in Q2 2021.
  • Over the past 5 years, Cogent Biosciences' Gains from Investment Securities peaked at $7.5 million during Q3 2020, and registered a low of -$1,000 during Q1 2019.
  • Over the past 3 years, Cogent Biosciences' median Gains from Investment Securities value was $2.9 million (recorded in 2021), while the average stood at $2.6 million.
  • In the last 5 years, Cogent Biosciences' Gains from Investment Securities crashed by 100.13% in 2019 and then soared by 449,266.30% in 2020.
  • Over the past 5 years, Cogent Biosciences' Gains from Investment Securities (Quarterly) stood at $3.2 million in 2017, then increased by 16.00% to $3.7 million in 2018, then plummeted by 42.16% to $2.1 million in 2019, then tumbled by 98.91% to $23,000 in 2020, then slumped by 50.20% to $3.7 million in 2021.
  • Its Gains from Investment Securities was $3.7 million in Q3 2021, compared to $4.1 million in Q2 2021 and $2.9 million in Q1 2021.